2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b)...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S291000

Reexamination Certificate

active

07601838

ABSTRACT:
The present invention relates to antithrombotic compounds 2-alkyl aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indole-3-carboxylic acid esters/amides, pharmaceutically acceptable salts and compositions thereof to be used in the treatment of intravascular thrombosis such as myocardial ischemia and stroke. The compound has the following general structurewherein R represents methyl ester or amide and R1represents alkyl, aryl and heteroaryl moiety.

REFERENCES:
patent: 6720330 (2004-04-01), Hay et al.
patent: 9718194 (1997-05-01), None
English Abstract Caplus DN 92:198594 Mohri Kunihiko et al., 1980.
Caplus , English Abstract DN 106:138683, The formation and intramolecular acylation of . . . Harrison David et al 1986.
Caplus English Abstract DN 112 : 76983 , 1990.
Caplus 117:171235 abstract IN 168420 Tripathi Ravish C., 1991.
English Abstract , DN 128:13253 , De Nanteuli et al , 1997.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b)... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b)... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4076739

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.